The management of Newron Pharmaceuticals S.p.A has overcome the opposition of a key shareholder and reached an agreement to acquire privately-held NeuroNova AB of Sweden in an all-share deal valued at €15.5 million. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
